Key result
RecordAF-AP prospective registry tracks real-world AF management and 12-month outcomes in ~3,000 Asia-Pacific patients.
Why the study?
The burden of atrial fibrillation and lack of data on its management in Asia Pacific highlight the need for a comprehensive prospective study of AF management in this region.
Observational (n=3,000)
Yes
Answers are grounded in this paper and cite their sources.
May inform Asia-Pacific AF practices once complete; leaves open optimal strategies pending outcomes data.
BACKGROUND: The literature suggests that the prevalence of atrial fibrillation (AF) may be lower in Asian countries than in Western countries. Nevertheless, AF remains a significant public health problem in the region. The burden of AF, the experiences of previous trials and the lack of data on AF and its management in Asia Pacific highlight the need for a comprehensive prospective study of AF management. METHODS: The REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation Asia Pacific (RecordAF-AP) is a prospective, observational survey of the management of recently diagnosed AF patients with 1-year follow-up in 8 countries across Asia Pacific. Eligible patients presenting with AF, treated or not, will be included in the registry and data will be recorded prospectively during follow-up visits at 6 and 12 months. RESULTS: RecordAF-AP will recruit more than 3000 patients. Study recruitment commenced in April 2009 and the final results anticipated at the end of 2011. CONCLUSIONS: RecordAF-AP will assess the real-life management of AF patients in Asia Pacific, including a comparison of clinical outcomes in rhythm versus rate control strategies, providing much needed insight into the costs, treatment choices and clinical outcomes of AF patients in this region.
No takes yet. Share an insight, caveat, or question.
Amerena et al. (2011) conducted an observational in Atrial Fibrillation (n=3,000). Atrial fibrillation management strategies (rhythm versus rate control) vs. Comparative real-world practice was evaluated on Rate of therapeutic success and the incidence of clinical outcomes in rhythm versus rate control strategies at 12 months. The RecordAF-AP prospective registry will evaluate real-world atrial fibrillation management strategies and 12-month clinical outcomes in over 3,000 patients across the Asia-Pacific region.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: